Basel Medical Group Ltd — Form F-1
Filed September 17, 2026 · analyzed by the Registration Agent
F-1
— Neutral
significance 28/100
What the filing says
Basel Medical Group Ltd (BVI company) filed Form F-1 to register up to 6,000,000 units for sale, each unit comprising one ordinary share (or pre-funded warrant) plus one common warrant. Cathay Securities acts as placement agent on best-efforts basis. Company will pay placement agent 6% cash fee (capped at US$400,000) plus up to US$60,000 in expenses. Specific offering price, number of units sold, and investor names are redacted [*]. Registration statement became effective [*], 2026. Company covenants 180-day lock-up on new equity issuances and grants placement agent 6-month right of first refusal on future capital raises.
Why this rating
Standard equity registration filing; no dollar amounts disclosed due to redactions. Routine FINRA-compliant capital raising structure with conventional terms. Immaterial without concrete offering size.
See more from September 17, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.